Ventripoint Announces Extension of Non-Brokered Unit Private Placement

Toronto, Ontario – TheNewswire - October 30, 2026 – Ventripoint Diagnostics Ltd. (“ Ventripoint ” or the “ Corporation ”, TSXV:VPT) announces that it will seek approval of TSX Venture Exchange (“ TSXV ” or the “ Exchange ”) to extend its previously announced non-brokered private placement (“ Offering ”) of up to 3,500,000 units (each, a “Unit”) at a price of $0.10 per Unit . The first tranche of the Offering closed on September 8, 2026. (See press release dated September 8, 2026). Each Unit will be comprised of one (1) common share (“Common Shares”) of the Corporation, and one (1) common share purchase warrant (“Warrants”). Each whole Warrant will entitle the holder thereof to purchase one (1) Common Share at a price of $0.14 for a period of 24 months from the closing of the Offering. The Corporation reserves the right to accelerate the Warrant expiry period upon 30 days notice if the Common Shares trade at $0.30 for a period of 10 consecutive days, including days where no trades occur. The Corporation will use the proceeds of the Offering to fund commercialization initiatives, advancement of Ventripoint’s core diagnostic technology platform and working capital. All securities issu

Free plan · Plus CA$29 or Pro CA$99/month